Pfizer's Dividend Freeze: A Cause for Concern?

Pfizer's dividend yield is currently at 6.20%, which is unusually high in big pharma.

This high yield can indicate either a mispriced income stock or a payout that the market has begun to doubt.

Pfizer had maintained its quarterly dividend increase every year for over a decade, but this streak broke in 2026.

The January 2026 ex-dividend payment was $0.43, matching the prior four quarters instead of rising as it had done previously.

The company's management has reaffirmed its commitment to maintaining and eventually growing the dividend, despite a challenging backdrop.

Pfizer's peers, Merck and Bristol-Myers Squibb, have continued to raise their dividends in 2026.